Similar articles for PMID: 29335263

Year	Number of Results
1968	1
1971	1
1975	1
1977	2
1978	2
1982	1
1983	1
1991	1
1994	1
1995	1
1996	4
1997	2
1998	1
1999	3
2002	1
2003	3
2005	3
2006	2
2007	3
2008	4
2010	5
2011	4
2012	3
2013	5
2014	2
2015	5
2016	9
2017	11
2018	2
2019	1
2021	2
2022	1
2024	0

1

Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.

Udow SJ, Freitas ME, Fox SH, Lang AE. Udow SJ, et al. CMAJ. 2018 Jan 15;190(2):E50-E52. doi: 10.1503/cmaj.170361. CMAJ. 2018. PMID: 29335263 Free PMC article. No abstract available.

2

Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.

Chou KL, Messing S, Oakes D, Feldman PD, Breier A, Friedman JH. Chou KL, et al. Clin Neuropharmacol. 2005 Sep-Oct;28(5):215-9. doi: 10.1097/01.wnf.0000180228.77802.32. Clin Neuropharmacol. 2005. PMID: 16239760 Clinical Trial.

3

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.

Morgan CJ, Curran HV. Morgan CJ, et al. Br J Psychiatry. 2008 Apr;192(4):306-7. doi: 10.1192/bjp.bp.107.046649. Br J Psychiatry. 2008. PMID: 18378995

4

Psychosis associated with synthetic cannabinoid agonists: a case series.

Hurst D, Loeffler G, McLay R. Hurst D, et al. Am J Psychiatry. 2011 Oct;168(10):1119. doi: 10.1176/appi.ajp.2011.11010176. Am J Psychiatry. 2011. PMID: 21969050 No abstract available.

5

Cannabis and cannabinoids.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2016 Aug 1;58(1500):97-8. Med Lett Drugs Ther. 2016. PMID: 27466748 No abstract available.

6

Products containing synthetic cannabinoids and psychosis.

Brakoulias V. Brakoulias V. Aust N Z J Psychiatry. 2012 Mar;46(3):281-2. doi: 10.1177/0004867411433974. Epub 2012 Jan 5. Aust N Z J Psychiatry. 2012. PMID: 22391292 No abstract available.

7

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.

van Amsterdam J, Brunt T, van den Brink W. van Amsterdam J, et al. J Psychopharmacol. 2015 Mar;29(3):254-63. doi: 10.1177/0269881114565142. Epub 2015 Jan 13. J Psychopharmacol. 2015. PMID: 25586398 Review.

8

Medical marijuana and the mind. More is known about the psychiatric risks than the benefits.

[No authors listed] [No authors listed] Harv Ment Health Lett. 2010 Apr;26(10):1-3. Harv Ment Health Lett. 2010. PMID: 20499454 No abstract available.

9

Synthetic cannabinoid overdose in a 20-year-old male US soldier.

Berry-Cabán CS, Ee J, Ingram V, Berry CE, Kim EH. Berry-Cabán CS, et al. Subst Abus. 2013;34(1):70-2. doi: 10.1080/08897077.2012.677754. Subst Abus. 2013. PMID: 23327506

10

Synthetic cannabinoid-induced psychosis: two adolescent cases.

Oluwabusi OO, Lobach L, Akhtar U, Youngman B, Ambrosini PJ. Oluwabusi OO, et al. J Child Adolesc Psychopharmacol. 2012 Oct;22(5):393-5. doi: 10.1089/cap.2012.0004. J Child Adolesc Psychopharmacol. 2012. PMID: 23083027 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year